Stock listing
Stuttgart:BO1 BioCryst Pharmaceuticals, Inc. Aktie
German listing (Stuttgart) of BioCryst Pharmaceuticals, Inc. · home listing NASDAQ:BCRX
Follow BioCryst Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:BCRX
$8.07 USD +0.28 (+3.6%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BCRX
- Day range
- $7.83 – $8.09 USDOct 19, 2026
- Volume
- 9.77M sharesOct 19, 2026
- Market value
- $2.06B USDAt the close on Oct 19, 2026 · price × 255.5M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BCRX · Home | $8.07 USD | +0.28 (+3.6%) | 9,774,006 | $7.84 | $8.085 | $7.828 | $7.79 | Close on Oct 19, 2026 |
| Frankfurt:BO1 | €7.076 EUR | -0.046 (-0.6%) | — | €6.876 | €7.076 | €6.876 | €7.122 | Close on Oct 19, 2026 |
| Munich:BO1 | €6.97 EUR | -0.24 (-3.3%) | — | €6.97 | €6.97 | €6.97 | €7.21 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:BCRX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $8.07 | +0.28 | +3.6% | $7.84 | $8.085 | $7.828 | 9,774,006 | |
| $7.79 | -0.23 | -2.9% | $7.96 | $8.015 | $7.74 | 4,396,151 | |
| $8.02 | -0.03 | -0.4% | $8.105 | $8.23 | $7.945 | 4,501,008 | |
| $8.05 | -0.02 | -0.2% | $8.02 | $8.18 | $7.97 | 5,648,300 | |
| $8.07 | -0.29 | -3.5% | $8.22 | $8.315 | $8.06 | 3,038,945 | |
| $8.36 | -0.19 | -2.2% | $8.49 | $8.55 | $8.24 | 3,466,900 | |
| $8.55 | +0.26 | +3.1% | $8.27 | $8.60 | $8.27 | 2,307,800 | |
| $8.29 | -0.11 | -1.3% | $8.36 | $8.40 | $8.13 | 5,121,500 | |
| $8.40 | +0.45 | +5.7% | $7.91 | $8.43 | $7.86 | 5,121,200 | |
| $7.95 | -0.15 | -1.9% | $8.15 | $8.15 | $7.87 | 3,939,400 | |
| $8.10 | -0.07 | -0.9% | $8.17 | $8.25 | $7.92 | 4,710,000 | |
| $8.17 | +0.05 | +0.6% | $8.12 | $8.20 | $7.92 | 6,148,700 | |
| $8.12 | -0.21 | -2.5% | $8.30 | $8.38 | $8.07 | 6,869,700 | |
| $8.33 | +0.06 | +0.7% | $8.28 | $8.42 | $8.18 | 13,099,000 | |
| $8.27 | -0.20 | -2.4% | $8.42 | $8.50 | $8.22 | 5,005,800 | |
| $8.47 | -0.12 | -1.4% | $8.56 | $8.66 | $8.34 | 4,354,700 | |
| $8.59 | +0.07 | +0.8% | $8.52 | $8.63 | $8.40 | 3,666,600 | |
| $8.52 | -0.05 | -0.6% | $8.54 | $8.65 | $8.40 | 4,853,000 | |
| $8.57 | -0.21 | -2.4% | $8.75 | $8.86 | $8.46 | 4,466,800 | |
| $8.78 | +0.02 | +0.2% | $8.87 | $9.04 | $8.72 | 3,442,300 | |
| $8.76 | +0.08 | +0.9% | $8.75 | $8.85 | $8.58 | 3,462,300 | |
| $8.68 | -0.02 | -0.2% | $8.60 | $8.84 | $8.49 | 12,746,800 | |
| $8.70 | +0.27 | +3.2% | $8.54 | $8.73 | $8.43 | 5,219,500 | |
| $8.43 | +0.27 | +3.3% | $8.15 | $8.45 | $8.11 | 5,859,500 | |
| $8.16 | -0.07 | -0.9% | $8.19 | $8.23 | $8.02 | 6,113,000 | |
| $8.23 | +0.11 | +1.4% | $8.17 | $8.38 | $8.10 | 5,096,600 | |
| $8.12 | -0.17 | -2.1% | $8.30 | $8.40 | $8.11 | 3,585,900 | |
| $8.29 | -0.52 | -5.9% | $8.34 | $8.46 | $8.05 | 9,000,900 | |
| $8.81 | -0.26 | -2.9% | $9.07 | $9.23 | $8.80 | 5,146,500 | |
| $9.07 | -0.89 | -8.9% | $9.12 | $9.40 | $8.96 | 9,687,000 | |
| $9.96 | -0.13 | -1.3% | $10.00 | $10.10 | $9.90 | 1,495,700 | |
| $10.09 | -0.08 | -0.8% | $10.15 | $10.22 | $9.94 | 1,973,800 | |
| $10.17 | +0.25 | +2.5% | $10.00 | $10.23 | $9.83 | 3,129,400 | |
| $9.92 | +0.22 | +2.3% | $9.72 | $9.96 | $9.63 | 3,357,300 | |
| $9.70 | -0.12 | -1.2% | $9.72 | $9.72 | $9.46 | 2,756,100 | |
| $9.82 | -0.05 | -0.5% | $9.82 | $9.96 | $9.72 | 2,702,900 | |
| $9.87 | +0.04 | +0.4% | $9.75 | $9.92 | $9.55 | 2,479,000 | |
| $9.83 | 0.00 | 0.0% | $9.77 | $9.90 | $9.71 | 1,858,900 | |
| $9.83 | +0.15 | +1.5% | $9.79 | $9.92 | $9.70 | 2,332,500 | |
| $9.68 | +0.13 | +1.4% | $9.50 | $9.76 | $9.48 | 2,010,200 | |
| $9.55 | -0.11 | -1.1% | $9.72 | $9.91 | $9.48 | 2,487,700 | |
| $9.66 | -0.41 | -4.1% | $9.92 | $9.99 | $9.60 | 2,329,200 | |
| $10.07 | +0.37 | +3.8% | $9.93 | $10.11 | $9.77 | 2,906,800 | |
| $9.70 | -0.24 | -2.4% | $9.89 | $9.94 | $9.55 | 2,122,100 | |
| $9.94 | +0.20 | +2.1% | $9.72 | $10.03 | $9.65 | 2,122,300 | |
| $9.74 | -0.07 | -0.7% | $9.68 | $9.80 | $9.46 | 3,820,800 | |
| $9.81 | -0.78 | -7.4% | $10.59 | $10.63 | $9.70 | 4,583,100 | |
| $10.59 | +0.25 | +2.4% | $10.33 | $10.68 | $10.10 | 3,865,600 | |
| $10.34 | +0.50 | +5.1% | $9.86 | $10.59 | $9.78 | 5,033,800 | |
| $9.84 | +0.46 | +4.9% | $9.33 | $9.86 | $9.28 | 4,017,100 | |
| $9.38 | +0.08 | +0.9% | $9.50 | $9.67 | $9.23 | 4,383,200 | |
| $9.30 | +0.23 | +2.5% | $9.04 | $9.53 | $8.98 | 4,044,200 | |
| $9.07 | +0.05 | +0.6% | $9.44 | $9.67 | $8.81 | 6,093,700 | |
| $9.02 | +0.21 | +2.4% | $8.82 | $9.04 | $8.76 | 2,920,900 | |
| $8.81 | -0.17 | -1.9% | $9.00 | $9.08 | $8.77 | 3,190,200 | |
| $8.98 | -0.26 | -2.8% | $9.17 | $9.25 | $8.93 | 2,929,000 | |
| $9.24 | -0.29 | -3.0% | $9.44 | $9.50 | $9.15 | 2,322,500 | |
| $9.53 | -0.21 | -2.2% | $9.66 | $9.79 | $9.51 | 2,194,900 | |
| $9.74 | +0.16 | +1.7% | $9.64 | $9.79 | $9.51 | 2,874,700 | |
| $9.58 | +0.24 | +2.6% | $9.64 | $9.91 | $9.58 | 4,310,300 | |
| $9.34 | -0.04 | -0.4% | $9.41 | $9.49 | $9.30 | 1,851,700 | |
| $9.38 | -0.13 | -1.4% | $9.32 | $9.48 | $9.25 | 1,635,300 | |
| $9.51 | +0.09 | +1.0% | $9.37 | $9.69 | $9.36 | 2,550,000 | |
| $9.42 | +0.31 | +3.4% | $9.18 | $9.43 | $9.11 | 2,291,000 | |
| $9.11 | -0.18 | -1.9% | $9.38 | $9.48 | $9.11 | 2,383,800 |
- Ticker
- Stuttgart:BO1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Oct 5, 2026
BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth
Latest earnings call · Aug 5, 2026
Biocryst Pharmaceuticals (NASDAQ:BCRX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · May 6, 2026
Q1 2026 Earnings Presentation
Earnings · 22 slides
Calls
Replays
Biocryst Pharmaceuticals (NASDAQ:BCRX) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 8:30 AM ET
Watch TranscriptBiocryst Pharmaceuticals (NASDAQ:BCRX) Q1 2026 Earnings Call
Wed, May 06, 2026 · 8:30 AM ET
Watch TranscriptBiocryst Pharmaceuticals (NASDAQ:BCRX) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 8:30 AM ET
Watch Transcript
Latest news
BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth
Oct 5, 2026
Closed $8.10 (-0.9%) on Oct 5, 2026
BioCryst Announces Approval of ORLADEYO® for Pediatric HAE Patients in Japan
Aug 25, 2026
Closed $9.83 (+1.5%) on Aug 25, 2026
BioCryst Reports Second Quarter 2026 Financial Results
Aug 5, 2026
Closed $9.07 (+0.6%) on Aug 5, 2026
BioCryst to Report Second Quarter 2026 Financial Results on August 5
Jul 22, 2026
Closed $9.51 (+1.0%) on Jul 22, 2026
BioCryst Appoints David W. Jenkins as Chief Scientific Officer
Jul 15, 2026
Closed $9.41 (-3.4%) on Jul 15, 2026
Decks
Q1 2026 Earnings Presentation
Earnings · 22 slides · May 6, 2026
Q4 2025 Earnings Presentation
Earnings · 21 slides · Feb 26, 2026
J.P. Morgan Healthcare Conference 2026
Conference · 23 slides · Jan 12, 2026
Q3 2025 Earnings Presentation
Earnings · 23 slides · Nov 3, 2025
BioCryst Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 29 in the last 12 months · 217 in all · newest Oct 5, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Aug 5, 2026
- Decks
- 29 decks · latest May 6, 2026
Where BioCryst Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BCRX · Home listing | NASDAQ | United States | USD |
| Tradegate:BO1 | Tradegate | Germany | EUR |
| gettex:BO1 | gettex | Germany | EUR |
| LS Exchange:896047 | LS Exchange | Germany | EUR |
| BMV:BCRX | BMV | Mexico | MXN |
| Lang & Schwarz:896047 | Lang & Schwarz | Germany | EUR |
| Frankfurt:BO1 | Frankfurt | Germany | EUR |
| BIVA:BCRX | BIVA | Mexico | MXN |
| BOATS:BCRX | BOATS | United States | USD |
| Stuttgart:BO1 · This page | Stuttgart | Germany | EUR |
| Dusseldorf:BO1 | Dusseldorf | Germany | EUR |
| Munich:BO1 | Munich | Germany | EUR |
| BX Swiss:BO1 | BX Swiss | Switzerland | CHF |
Log in to ask 6ix AI your own questions about BioCryst Pharmaceuticals, Inc.